Virbac launches innovative mobility supplements to support active and ageing dogs’ muscle and joint health
Virbac introduces URSOLYX Soft Chews and MOVOFLEX Advanced Soft Chews, aiming to enhance muscle and joint support in active and ageing dogs, with some animals showing improvement within a week.
For veterinarians advising clients with active dogs, the message from Virbac is straightforward: mobility support is not just about ageing joints, but also about preserving muscle and overall function across an animal’s working life.
According to the company, URSOLYX Soft Chews are formulated with ursolic acid, a compound derived from fruits and herbs, to help maintain muscle mass and support strength in dogs that are ageing, highly active or recovering. Virbac says the once-daily chew is intended to help dogs keep walking, running, jumping and playing with less decline in muscle function over time.
The company is making a similar case for MOVOFLEX Advanced Soft Chews, which it describes as a daily mobility supplement for dogs at all life stages. Virbac says the formula combines seven ingredients, including krill, hyaluronic acid, astaxanthin, boswellic acid, vitamin D3 and BIOVAFLEX egg shell membrane, to support hip and joint mobility, cartilage, lubrication and bone health. The product is positioned as fast-acting, with the company saying some dogs may show improvement within seven days.
For clinical practice, the broader takeaway is familiar: active dogs need more than exercise advice alone. Nutritional and supplement strategies may help preserve the musculoskeletal systems that underpin performance, comfort and longevity, particularly in dogs with high athletic demands or early age-related decline. Virbac is clearly targeting that overlap between sport, ageing and preventive care.
Image Source: Virbac
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."